BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. BRCA1, Fatty acid metabolic process, Lung cancer, Intestine, Neocentromeres)
Bookmark Forward

QuickView for FXa (gene)


Body Atlas

Most Correlated Tissues

  1. Vena cava
  2. Liver
  3. Macrophage of peripheral blood
  4. Natural killer cell of peripheral blood
  5. Fetal liver
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Blood coagulation disorder
  2. Stachybotryotoxicosis
  3. Ischemic reperfusion injury
  4. Infection due to Staphylococcus aureus
  5. Disease caused by parasite
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. factor VIII, von Willebrand factor drug combination
  2. 3-hydroxyaspartic acid
  3. recombinant FVIIa
  4. Enoxaparin
  5. polidocanol
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. LEP
  2. TBC1D23
  3. PADI2
  4. SORD
  5. BATF3
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associ…
  2. Synthesis of pyrrolo[3,2-d]pyrimidineone derivatives as novel FXa inhibitors.
  3. Monitoring anti-factor Xa activity in patients with chronic thromboembolic pulmonary hypertension tr…
  4. Novel Isosteviol-Based FXa Inhibitors: Molecular Modeling, In Silico Design and Docking Simulation.
  5. Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless fact…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Trial of Andexanet Alfa in ICH Patients Receiving an Oral FXa Inhibitor
  2. Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery
  3. Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant
  4. Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote
  5. The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Ora…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.